Clinical trial

Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease

NCT01918488

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIETARY_SUPPLEMENT · Unmapped registry intervention Standardized salt diet Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Amiloride Normalized identity: amilorideView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2013-10-01

PhaseNA

Conditions

Diabetic Nephropathiesunresolved

Hypertensionunresolved

Interventions

Standardized salt dietDIETARY_SUPPLEMENT

AmilorideDRUG · verified · RxNorm: amiloride

Sponsors & collaborators

University of Southern Denmarklead sponsor

Odense University Hospitalcollaborator

Region of Southern Denmarkcollaborator

The Ministry of Science, Technology and Innovation, Denmarkcollaborator

Danish Heart Foundationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01918488 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.